# Progress Note 01 — Initial plan

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Srinivasa Ramanujan (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-ET020-SYN
- Date: 2026-01-12
- Fictional facility: St. Posthumous Health Center
- Fictional author: Edmund Ashworth, MD
- Calendar frame: modern shifted

## Subjective

The patient participates in this fictional visit for new patient with four weeks of evening fevers and night sweats, weight loss and right upper quadrant pain, in a 29-year-old mathematician from Tamil Nadu who came to a research fellowship here three years ago. **S**

## Objective

White blood cells: 13.6 10*3/uL (high); Hemoglobin: 11.2 g/dL (low); Mean cell volume: 99 fL; Platelets: 412 10*3/uL (high); C-reactive protein: 92 mg/L (high); Sodium: 134 mmol/L (low); Potassium: 4.1 mmol/L; Creatinine: 0.94 mg/dL; eGFR (CKD-EPI 2021): 113 mL/min/1.73 m²; Alkaline phosphatase: 214 U/L (high); ALT: 46 U/L (high); AST: 38 U/L; Bilirubin, total: 0.9 mg/dL; Albumin: 3.2 g/dL (low); Hemoglobin A1c: 5.4%; Vitamin B12: 168 pg/mL (low); Folate: 12.4 ng/mL; Ferritin: 310 ng/mL; 25-hydroxyvitamin D: 9 ng/mL (low); PHQ-9: 12; GAD-7: 9. All results are synthetic.

BP 112/70 mmHg; pulse 104 bpm; respirations 18/min; temperature 38.4 °C; oxygen saturation 97% on room air; weight 52 kg; BMI 19.1 kg/m². All vital signs are synthetic.

## Assessment

Active problems: Evening fevers to 38.6 °C with night sweats for about four weeks; Weight loss of 5 kg over two months (57 to 52 kg), with poor appetite; Dull right upper quadrant pain for three weeks, worse on deep breathing and lying on the right side, with a tender liver edge; Vitamin B12 deficiency from a strict vegetarian diet (B12 168 pg/mL), with anemia (hemoglobin 11.2 g/dL, MCV 99 fL) to which inflammation also contributes; Vitamin D deficiency (25-hydroxyvitamin D 9 ng/mL); Adjustment disorder with depressed mood (PHQ-9 12, no thoughts of self-harm) during a serious illness, far from his wife and family. Strengths and supports remain part of the care plan. **S**

## Medication changes

- No medication changes. **S**

## Plan

- Infectious diseases consultation at the second visit for fever, weight loss and right upper quadrant pain in a young man from South India with a history of dysentery, to interpret the tuberculosis and amebiasis tests, the imaging, and the choice and order of treatment. Guideline: Official American Thoracic Society/Infectious Diseases Society of America/Centers for Disease Control and Prevention Clinical Practice Guidelines: Diagnosis of Tuberculosis in Adults and Children (2017); DPDx: Amebiasis (laboratory diagnosis, including antibody detection in extraintestinal disease) (2026) **S**
- Tuberculosis evaluation before any antibiotic: chest radiograph, three induced sputum samples for acid-fast smear, NAAT and mycobacterial culture, an interferon-gamma release assay, and HIV testing; airborne precautions until three smears are negative. Guideline: Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis (2016); Official American Thoracic Society/Infectious Diseases Society of America/Centers for Disease Control and Prevention Clinical Practice Guidelines: Diagnosis of Tuberculosis in Adults and Children (2017) **S**
- Liver and gut evaluation: abdominal ultrasound tomorrow morning, Entamoeba histolytica serology, stool antigen or PCR and microscopy, two sets of blood cultures, liver tests and CRP. Guideline: DPDx: Amebiasis (laboratory diagnosis, including antibody detection in extraintestinal disease) (2026); A Review of the Global Burden, New Diagnostics, and Current Therapeutics for Amebiasis (2018) **S**
- Nutrition: vitamin B12, folate, ferritin and 25-hydroxyvitamin D measured; weight at every visit; a dietitian visit to plan meals within his vegetarian diet and his rules. Guideline: Position of the Academy of Nutrition and Dietetics: Vegetarian Diets (2016); CMID: Clinical Monitoring Intelligence Database, anemia and depression monographs (2026) **S**
- Mood and safety: PHQ-9 and GAD-7 at intake and at least monthly while symptoms last; structured safety assessment and a written safety plan with the 988 Suicide & Crisis Lifeline; safety reviewed at every visit; short-term counseling with the university counseling service, at times he chooses. Guideline: CMID: Clinical Monitoring Intelligence Database, anemia and depression monographs (2026); Depression and Suicide Risk in Adults: Screening (2023); VA/DoD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide (2024) **S**
- Support far from home: the university's international student office and his department's graduate office about leave and deadlines while he is ill; a regular time to call his family; introductions, at his wish, to the local Tamil association and a Hindu temple community with shared meals; a letter for his fellowship about his illness. Guideline: Depression and Suicide Risk in Adults: Screening (2023) **S**
- Acetaminophen for fever and pain, no more than 3 g a day; nothing else until the results are known. Guideline: DPDx: Amebiasis (laboratory diagnosis, including antibody detection in extraintestinal disease) (2026) **S**
